Rankings
▼
Calendar
IRWD FY 2017 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
IRWD
Ironwood Pharmaceuticals, Inc.
$603M
FY 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$298M
+8.9% YoY
Gross Profit
$279M
93.5% margin
Operating Income
-$77M
-25.9% margin
Net Income
-$117M
-39.2% margin
EPS (Diluted)
$-0.78
Cash Flow
Operating Cash Flow
-$100M
Free Cash Flow
-$104M
Stock-Based Comp.
$34M
Balance Sheet
Total Assets
$606M
Total Liabilities
$596M
Stockholders' Equity
$10M
Cash & Equivalents
$126M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$298M
$274M
+8.9%
Gross Profit
$279M
$272M
+2.5%
Operating Income
-$77M
-$52M
-49.2%
Net Income
-$117M
-$82M
-43.1%
← Q4 2016
All Quarters
Q1 2017 →